Clinical data points and collection methods
| Chart review | Baseline (Intake questionnaires) | Questionnaires 6 months after return of results | |
| Underlying conditions Hypertension, chronic cardiac disease, coronary artery disease, congestive heart failure, obesity, chronic metabolic disease, chronic lung disease, chronic neurologic disease, dementia, renal disease, chronic immunosuppressive disease, liver disease, blood disorder, autoimmune/rheumatological disorder, chronic haematological/blood disorder, liver disease, pregnancy, endocrine disorder, cardiovascular disorder, cancer/malignant neoplasm, gastrointestinal disorder, lipid disorders, viral infection, tuberculosis. | x | x | |
| COVID-19 symptoms and duration Cough, fever, sore throat, runny nose wheezing, shortness of breath, lower chest wall in-drawing, chest pain, conjunctivitis, lymphadenopathy, headache, loss of smell (anosmia), loss of taste (ageusia), seizures, fatigue/malaise, anorexia, altered consciousness/confusion, muscle aches (myalgia), joint pain (arthralgia), inability to walk, abdominal pain, diarrhoea, vomiting/nausea, skin rash, bleeding, other symptoms. | x | x | |
| COVID-19 complications Pneumonia, acute respiratory distress syndrome, pneumothorax, pleural effusion, bronchiolitis, seizure, stroke, congestive heart failure, heart infection, cardiac arrhythmia, cardiac ischaemia, cardiac arrest, bacteraemia, coagulation clotting disorder, anaemia, rhabdomyolysis/myositis, kidney failure/injury, gastrointestinal haemorrhage, pancreas infection, liver injury/failure, hyperglycaemic, hypoglycaemic, other. | x | x | |
| Procedures performed during hospitalisation Non-invasive ventilation (eg, BIPAP, CPAP), invasive ventilation, extra corporeal life support, high-flow nasal canula oxygen therapy, dialysis/haemofiltration, medications (eg, dopamine, epinephrine, vasopressin, neuromuscular blocking agents, antibiotics), tracheostomy, nitric oxide inhalation, prone positioning, other intervention or procedure. | x | x | |
| Tests performed during hospitalisation Chest CT, chest X-ray, ECG, ultrasound, other tests | x | x | |
| Laboratory tests to assess physiological response Haemoglobin, white cell count, lymphocyte count, neutrophil count, haematocrit, platelets, blood gases, activated partial thromboplastin time ratio, prothrombin time, ALT/SGPT, total bilirubin, AST/SGOT, procalcitonin, BNP, NT-pro-BNP, C reactive protein, ferritin, cytokine IL-6, glucose, lactate, sodium, potassium, albumin, LDH, creatinine, urea, cardiac troponin I, D-dimer, fibrinogen | x | ||
| Risk factors Smoking/vaping, diet, BMI | x | x | |
| COVID-19 vaccination Vaccination status, vaccine type, number of doses, side effects. | x | x |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BIPAP, bilevel positive airway pressure; BMI, body mass index; BNP, B-type natriuretic peptide; CPAP, continuous positive airway pressure; LDH, lactate dehydrogenase; NT-pro-BNP, N-terminal pro b-type natriuretic peptide; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamic-pyruvic transaminase.